Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic pelvic lymphadenectomy

W Boeckmann1, P Effert, J M Wolff

  • 1Department of Urology, Medical Faculty of Technical University (RWTH), Aachen.

Acta Urologica Belgica
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evaluation of long-term effects after chemoprevention of prostate cancer].

Der Urologe. Ausg. A·2019
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Testosterone in the management of metastatic prostate cancer].

Der Urologe. Ausg. A·2015
Same author

Adaptive Radiotherapy Using Deformable Image Registration - A Concept for Individualised Radiation Treatments.

Biomedizinische Technik. Biomedical engineering·2013
Same author

[Value of intermittent androgen deprivation in the context of the current data situation].

Aktuelle Urologie·2013
Same author

[Pathophysiology and therapy of castration-resistant prostate cancer].

Der Urologe. Ausg. A·2012
Same journal

[Isolated Echinococcus cyst of the kidney].

Acta urologica Belgica·2001
Same journal

[Penis fracture: mechanism, evaluation, treatment and treatment outcome].

Acta urologica Belgica·2001
Same journal

[Treatment of posttraumatic rupture of the posterior part of the urethra using endoscopic reconstruction].

Acta urologica Belgica·2001
Same journal

[Malignant adrenal gland tumors. A case report and an overview of the literature].

Acta urologica Belgica·2001
Same journal

[Prostate cancer and nutrition].

Acta urologica Belgica·2001
Same journal

[Role of the partner after placement of a penis prosthesis due to erectile dysfunction].

Acta urologica Belgica·2001
See all related articles

Laparoscopic pelvic lymph node dissection (LPLND) accurately stages localized prostate cancer. This minimally invasive procedure showed a low complication rate, aiding treatment decisions for patients with pelvic lymph node metastases.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Prostate cancer staging is crucial for treatment selection.
  • Accurate staging requires assessment of lymph node involvement.
  • Minimally invasive staging techniques are desirable.

Purpose of the Study:

  • To evaluate the efficacy and safety of laparoscopic pelvic lymph node dissection (LPLND) as a staging procedure for localized prostate cancer.
  • To determine the rate of pelvic lymph node metastases in patients undergoing LPLND.
  • To assess the complication rate associated with LPLND.

Main Methods:

  • Retrospective analysis of the first 41 patients with localized prostate cancer treated with LPLND.
  • LPLND was performed as a staging procedure prior to radical perineal prostatectomy or interstitial radiotherapy.

Related Experiment Videos

  • Pelvic lymph node status was assessed, and patients with metastases received endocrine therapy.

    • Main Results:

    • 17% (7/41) of patients had pelvic lymph node metastases.
    • The overall complication rate was low at 7.5%.
    • No major complications were reported during the study period.

    Conclusions:

    • Laparoscopic pelvic lymph node dissection (LPLND) is a safe and effective minimally invasive method for staging localized prostate cancer.
    • LPLND provides accurate staging information, identifying patients with lymph node metastases who may benefit from additional therapy.
    • The low complication rate supports the use of LPLND in the management of prostate cancer.